In this on-demand webinar hosted by Respiplus on expandCourses.com, pharmacist educator Mike Boivin and Professor David Strain address the continued urgency of COVID-19 management for high-risk patients. Despite shifting global attention, COVID-19 remains a serious risk, particularly with new variants impacting hospitalization rates. The speakers share current insights on these variants and provide practical strategies to safeguard vulnerable populations.

Objectives

This webinar equips healthcare professionals with essential tools and up-to-date strategies to continue protecting high-risk patients and managing COVID-19’s ongoing challenges.

  • Understand Current COVID-19 Trends: Gain insights into the latest COVID-19 variants, infection patterns, and how these are affecting high-risk groups in Canada, the UK, and globally.

  • Highlight the LIFE Model for COVID-19 Care: Learn about the LIFE model, a targeted approach to identifying at-risk patients, improving testing access, facilitating treatment, and engaging patients, which can help clinicians reduce hospitalizations and complications.

  • Implement Action Plans to Enhance Patient Preparedness: Understand the critical role of an actionable plan for at-risk patients, ensuring they know steps to take if symptoms appear, from testing to accessing treatment.

  • Address Challenges in COVID-19 Care: Identify solutions to common care barriers, including delayed access to testing and treatment, to better support timely and effective patient management.

Enroll Now - it's free

Prevention doesn’t end with a vaccine; it requires ongoing, strategic intervention for those at greatest risk.

Get started now

Takeaways

  • COVID-19 Remains a Threat for High-Risk Populations: New variants are contributing to increased hospitalizations, emphasizing the need for continued vigilance in patient care.

  • The LIFE Model for Improved Patient Outcomes: The LIFE model provides a structured approach to identify, test, treat, and follow up with high-risk patients, reducing the likelihood of severe outcomes.

  • The Essential Role of Action Plans: Action plans empower patients and caregivers to take swift, informed steps if COVID-19 symptoms arise, streamlining access to timely care and treatment.

  • Proactive Testing and Treatment Access: Early testing and rapid treatment can prevent hospitalization, but barriers in healthcare settings need to be addressed to ensure high-risk patients get timely support.

  • Current Evidence and Best Practices for Clinicians: The webinar covers the latest research, equipping clinicians with actionable insights and resources to enhance COVID-19 care and reduce long-term complications.

Course curriculum

  • 1

    Introduction

    • Introduction
  • 2

    Chapter 1: What is the current situation for COVID-19 by end of 2024?

    • What is the current situation for COVID-19 by end of 2024?
  • 3

    Chapter 2: The impressive low uptake of vaccines, treatments and consequences on the healthcare system

    • The impressive low uptake of vaccines, treatments and consequences on the healthcare system
  • 4

    Chapter 3: Why is it so important to have a plan in place for High -risk individuals?

    • Why is it so important to have a plan in place for High-risk individuals?
  • 5

    Chapter 4: What is the LIFE model for COVID-19 Care?

    • What is the LIFE model for COVID-19 Care?
  • 6

    Chapter 5: New Evidence for the impact of Paxlovid

    • New Evidence for the impact of Paxlovid
  • 7

    Chapter 6: Why is it so important to establish an Action Plan with your patients?

    • Why is it so important to establish an Action Plan with your patients?
  • 8

    Chapter 7: The shockingly low uptake of vaccines and what to do for your high-risk patients

    • The shockingly low uptake of vaccines and what to do for your high-risk patients
  • 9

    Thank you for watching!

    • Thank you for watching!

    • Join Our Upcoming Webinar: Engage with Experts on COVID-19 Protection for High-Risk Populations

About our speakers

Michael Boivin

Pharmacist, Medical Writer, CME Planner

Mike Boivin, Pharmacist, Medical Writer, CME Planner is a Pharmacist Educator based in Barrie, Ontario, with over two decades of experience in healthcare education. He has developed over 100 programs on immunization and chronic disease management for healthcare professionals across Canada and internationally. Known for his expertise increating accessible, evidence-based educational content, Mike collaborates with clinicians and healthcare organizations to advance patient care. His work focuses on practical strategies for managing high-risk populations, witha particular emphasis on COVID-19, influenza, and respiratory illnesses.

Professor David Strain

BSc Hons, MB ChB, MD, FRCP

Professor David Strain, BSc Hons, MB ChB, MD, FRCPis a Senior Clinical Lecturer at the University of Exeter Medical School and a Consultant Physician specializing in diabetes and COVID-19 care. He previously served as the Clinical Lead for COVID-19 Services in Exeter and is the Chair of the British Medical Association’s Board of Science. With extensive experience in managing high-risk populations, Prof. Strain is also a recognized advocate for evidence-based strategies in post-viral illness care, including Long COVID. His research focuses on proactive healthcare approaches, ensuring that vulnerable patients receive timely, effective interventions.

Join Our Upcoming Webinar: Engage with Experts on COVID-19 Protection for High-Risk Populations

To continue exploring critical insights on COVID-19 and its impact on high-risk populations, join our upcoming Q&A webinar where you can directly engage with experts Mike Boivin and Professor David Strain. This interactive session offers you the unique opportunity to ask your questions and deepen your understanding of protective strategies against COVID-19.

  • Free

    FreeQ&A Session: COVID-19 – Protecting High-Risk Populations Today (Webinar Replay)

    Join our experts in this FREE 60-minute Q&A session and gain essential insights on Managing COVID-19 for High-Risk Populations
    Register Now

This program has received educational funding from Pfizer Canada, supporting Respiplus in delivering valuable COVID-19 insights for healthcare professionals.